Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
HyperFusion High-Fidelity DNA Polymerase: Precision for GC-R
2026-07-24
HyperFusion™ high-fidelity DNA polymerase enables robust, error-free PCR amplification in the most challenging templates, including GC-rich and long DNA sequences. Its unmatched fidelity and inhibitor resistance accelerate neurogenetic studies and high-throughput workflows where standard enzymes fail.
-
Rapid Purification of Recombinant Annexin V for Biophysical
2026-07-24
This study introduces a streamlined protocol for obtaining highly pure recombinant annexin V, crucial for precise biophysical and structural studies. By leveraging calcium-mediated binding and gentle cell lysis, the method addresses contamination challenges and sets a new standard for protein preparation in annexin research.
-
KR-12 (Human) TFA: Precision Antimicrobial Design and Assay
2026-07-23
Explore the science behind KR-12 human antimicrobial peptide, focusing on precision assay design, mechanism-driven applications, and practical guidance for translational research. Discover how this unique fragment advances peptide research beyond standard reviews.
-
Danazol (Danocrine): Mechanisms, Evidence & Research Protoco
2026-07-23
Danazol is a synthetic weak androgen used for probing steroidogenesis and androgen receptor signaling pathways. It inhibits steroidogenic enzymes and suppresses luteinizing hormone (LH), making it valuable in endocrine and oncology research. High-purity Danazol from APExBIO supports reproducible experimental outcomes.
-
Auranofin: Thioredoxin Reductase Inhibitor for Cancer Resear
2026-07-22
Auranofin, a potent thioredoxin reductase inhibitor from APExBIO, empowers researchers to dissect redox biology, apoptosis, and radiosensitization in diverse cancer models. This guide delivers optimized workflows, troubleshooting strategies, and translational insights for maximizing reproducibility and scientific impact.
-
DNase I (RNase-free): Precision DNA Removal for Advanced RNA
2026-07-22
DNase I (RNase-free) from APExBIO empowers researchers to achieve superior DNA removal in RNA extraction, RT-PCR, and chromatin studies. Its strict RNase-free formulation and versatile cation activation drive reproducible, contamination-free molecular biology workflows.
-
ML385 and NRF2 Inhibition: Beyond Cancer—Insights from Neuro
2026-07-21
Explore how ML385, a leading NRF2 inhibitor, is revolutionizing both cancer and neurodegeneration research. This article uniquely connects NRF2 pathway inhibition to ferroptosis and cognitive decline, providing assay guidance grounded in the latest scientific advances.
-
Tioconazole in Antifungal Drug Development: Protocols & Insi
2026-07-21
Tioconazole stands out as a high-purity antifungal medication for robust in vitro and in vivo modeling of fungal infections, with precisely defined solubility and mechanism parameters. This article breaks down advanced workflows, troubleshooting, and recent research-driven innovations to help scientists optimize antifungal assays and understand cross-domain implications.
-
Amitriptyline HCl: Technical Guidance for Neuropharmacology
2026-07-20
Amitriptyline HCl (SKU B2231) is a tricyclic compound optimized for reproducible studies of neurotransmitter receptor modulation in neuropharmacology and mood disorder models. It addresses key challenges in solubility, stability, and assay reproducibility. This product is not suitable for speculative or non-dossier-supported applications outside receptor modulation and related neuropsychiatric disorder research.
-
Calnexin’s Role in CFTR Variant Rescue and VX-661 Modulation
2026-07-20
Tedman et al. systematically profiled how the chaperone calnexin influences plasma membrane expression and pharmacological rescue of over 200 CFTR variants. Their deep mutational scanning reveals domain- and variant-specific dependencies on calnexin for CFTR corrector efficacy, providing crucial insight for cystic fibrosis research and personalized therapeutic strategies.
-
Mestranol Reversibly Induces Lysosomal Stress in Zebrafish M
2026-07-19
This study establishes that mestranol, a synthetic estrogen, triggers a reversible lysosomal storage–like state in zebrafish microglia without altering neuronal apoptosis or cell number. The work provides a live, dynamically controllable model for dissecting the neuroimmunotoxic impact of environmental estrogens on microglial lysosomal function.
-
PBS (Phosphate-Buffered Saline): Technical Workflow Guide
2026-07-18
PBS (Phosphate-Buffered Saline, SKU K2818) is a sterile, isotonic buffer formulated to maintain physiological pH and osmolarity in laboratory workflows like cell washing and dilution. It should be used exclusively for in vitro scientific research, not for diagnostic or medical applications.
-
Sunitinib: Multi-Targeted RTK Inhibitor Workflows in Oncolog
2026-07-17
Unlock robust cancer models with Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor proven to induce apoptosis and disrupt angiogenesis. This article distills advanced workflows, troubleshooting tips, and a research-driven look at ATRX-deficient glioma sensitivity, positioning Sunitinib as an indispensable tool for translational oncology studies.
-
Homer1a Modulates Caspase-6 to Attenuate Inflammatory Pain
2026-07-17
The referenced preclinical study demonstrates that Homer1a suppresses caspase-6 and TNF-α signaling, reducing inflammatory pain in a rat model. This finding highlights the Homer1a/caspase-6 axis as a promising target for pain research and provides mechanistic insights relevant to neuroinflammatory disease models.
-
Self-Amplifying RNA Vaccines Show Enhanced Immunity for Infl
2026-07-16
This study demonstrates that self-amplifying RNA (saRNA) vaccines significantly improve immunogenicity and dose efficiency against seasonal influenza, particularly influenza B, compared to traditional mRNA and circular RNA platforms. These findings have important implications for future vaccine design and for molecular workflows requiring precise RNA preparation.